Skip to main content

Entacapone Tablets

Type of Posting: Revision Bulletin

Posting Date: 31–Jan–2014

Official Date: 01–Feb–2014

Expert Committee: Monographs—Small Molecules 4

Reason for Revision: Compliance

In accordance with the Rules and Procedures of the 2010–2015 Council of Experts, the Monographs—Small Molecules 4 Expert Committee has revised the Entacapone Tablets monograph. The purpose for the revision is to add Dissolution Test 2 and Dissolution Test 3 for drug products approved by the FDA. Additionally, minor editorial changes have been made to update the monograph to current USP style.

The Entacapone Tablets Revision Bulletin supersedes the currently official Entacapone Tablets monograph. The Revision Bulletin will be incorporated in Second Supplement to USP 37–NF 32.

Should you have any questions, please contact H. Joyce (301-998-6792 or HRJ@usp.org).